WPS PART A-Outpatient Hospital Only
None at this time.
WPS PART B-Private Practice Only
WPS PART A & PART B
2019 MAC Satisfaction Indicator (MSI): Coming in March 2019!
The 2019 MAC Satisfaction Indicator (MSI), a survey administered by the Centers for Medicare & Medicaid Services (CMS), is coming in March. The MSI measures your satisfaction with our processes and service delivery so we can gain valuable insights and determine process improvements. Thanks for your feedback in 2018. We used your feedback to make improvements to our services, and here are examples of improvements we made:
Watch for the survey on our website to participate in the 2019 survey.
Draft Local Coverage Determination (LCD): We Want Your Comments
The following DRAFT LCDs are open for comment. Comments will be accepted until April 8, 2019, and can be sent to policycomments@wpsic.com. Please include the topic of the LCD on the e-mail subject line. Please include published scientific studies and/or literature to support additional coverage.
LCD Database ID Number | Draft LCD Title | CMD |
DL38018 | MolDX: DecisionDX - Melanoma | Dr. Ella Noel |
Individual responses to the comments will not be sent. Responses will be available in a Comment and Response document that is posted with the Final LCD.
Additional information is located on the WPS GHA Proposed/Draft Local Coverage Determinations (LCD) page.
Future Article for Human Granulocyte/Macrophage Colony Stimulating Factors Billing and Coding Guidelines
A future Coverage Article for Human Granulocyte/Macrophage Colony Stimulating Factors Billing and Coding Guidelines is replacing LCD L34699 Human Granulocyte/Macrophage Colony Stimulating Factors, which has an anticipated retirement date of March 18, 2019.
The new article supports human granulocyte colony-stimulating factors drugs that are produced by recombinant DNA technology with the use of bacteria and a human G-CSF gene. G-CSF regulates the production of neutrophils (a WBC) within the bone marrow (where blood cells are manufactured naturally in the body). Neutrophils are an essential in the body's fight against infections.
The new article will efficiently support the billing and coding guidance that was in L34699. A lapse in coverage will not occur.
The future article will be viewable February 1, 2019, on the Medicare Coverage Database and on the WPS GHA Local Coverage Determination (LCDs) and Coverage Articles web page.
Changes to the Local Coverage Determination (LCD) Process
Information related to the new LCD process is available on our Policies Guides and Resources web page.
MEDICARE HOT LINKS
Addendum B Update (HOPPS Fee Schedule for Services & Drugs)
Current ASP Drug Pricing Files
Quarterly Updated to CCI Edits
2019 FINAL RULES
Physician Fee Schedule Fact Sheet